Emily, a 12-year-old Labrador retriever, is facing age-related health issues, triggering her owner Maxine Clegg's emotional reflections on their bond. Most pet owners, like Clegg, are willing to go into debt for their pets' well-being. To address aging in dogs, Celine Halioua founded Loyal, a biotech company focused on developing preventive medicine to combat age-associated diseases. Halioua aims for the FDA approval of LOY-002, a drug targeting healthy lifespan extension in dogs, marking potential advancements in canine health care.
Clegg, a schoolteacher, tears up at the idea of losing her best friend one day. "I don't know life without her and I'd do whatever it takes to give her more time with us."
The goal of the company from Day 1 has always been to get the first drug FDA approved for healthy lifespan extension, Halioua told Slate.
Collection
[
|
...
]